STRO · Sutro Biopharma, Inc. · Executive Compensation

$9.20 -0.74 (-7.44%) At close · Nov 5

Russell 2000 member Rebalance outlook locked

Market Cap

$153.71M

16.58M

Volume · Nov 5 771.86K Avg daily vol (3M) 319.6K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William J. Newell	Former Chief Executive Officer	$239,693	—	—	—	—	$1,431,618	$1,671,311
Jane Chung	R.Ph. Chief Executive Officer	$652,000	—	$167,400	$245,280	$465,750	$45,500	$1,575,930
Hans-Peter Gerber	Chief Scientific Officer	$527,532	—	$61,425	$110,127	$243,818	—	$942,902
Gregory Chow	Chief Financial Officer	$277,083	$25,000	$88,000	$245,938	$218,500	—	$854,522

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William J. Newell	Former Chief Executive Officer	$707,500	—	$758,180	$589,373	$277,290	—	$2,332,343
Jane Chung	R.Ph. Chief Executive Officer	$560,000	—	$454,000	$169,360	$182,000	$78,000	$1,443,360
Hans-Peter Gerber	Chief Scientific Officer	$512,500	$100,000	$204,300	$203,232	$133,900	—	$1,153,932

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William J. Newell	Chief Executive Officer	$496,500	—	—	$3,097,200	$223,425	—	$3,817,125
Trevor J. Hallam	Chief Scientific Officer	$418,000	—	—	$330,600	$150,480	$132,000	$1,031,080
Arturo Molina	M.D., M.S., FACP Chief Medical Officer	$453,500	—	—	$330,600	$163,260	—	$947,360

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
William J. Newell	Chief Executive Officer	$482,000	—	$1,136,355	$6,764,993	$301,250	—	$8,684,598
Trevor J. Hallam	Chief Scientific Officer	$405,800	—	$702,465	$2,951,998	$202,900	$132,000	$4,395,163
Arturo Molina	M.D., M.S., FACP Chief Medical Officer	$440,300	—	$387,390	$2,306,240	$220,150	—	$3,354,080

Executive changes

Person	Role	Change	Effective	Filed
Gregory K. Chow	Chief Financial Officer, principal financial officer and principal accounting officer	Appointed	2025-06-02	2025-06-02
Jane Chung	Chief Executive Officer	Appointed	2025-03-13	2025-03-13
Jane Chung	Class II Director	Appointed	2025-03-13	2025-03-13
Edward C. Albini	Chief Financial Officer	Resigned	2025-05-15	2025-03-13
William J. Newell	Director	Resigned	2025-03-13	2025-03-13
William J. Newell	President and Chief Executive Officer	Resigned	2025-03-13	2025-03-13
Sukhi Jagpal	Class III director	Appointed	2024-08-08	2024-08-12
Jane Chung	President and Chief Operating Officer	Appointed	2023-12-01	2023-11-21
Dr. Trevor Hallam	President of Research and Chief Scientific Officer	Resigned	2023-05-31	2023-04-27
Heidi Hunter	Chair of the Audit Committee	Appointed	2023-04-13	2023-04-14
Shalini Sharp	Class III director and as the Chair of the Audit Committee of the Board	Resigned	2023-04-10	2023-04-14
Dr. Arturo Molina	Chief Medical Officer	Resigned	2022-11-04	2022-10-24

Leadership

Jane Chung CEO, COO, Board Member
Gregory Chow CFO
Gregory K. Chow CFO
David Pauling General Counsel
Heidi Hunter Board Member
James Panek Board Member
Jon Marc Wigginton, M.D. Board Member
Sukhi Jagpal Board Member

Key facts CIK 1382101 CUSIP 869367201 13F (30d) 31 filings 19 filers Visit website Investor relations